Department of Medical Physics, Tata Memorial Hospital, Mumbai, India.
Radiother Oncol. 2013 Apr;107(1):58-62. doi: 10.1016/j.radonc.2013.01.011. Epub 2013 Feb 27.
Evaluation of Inter-application variation of doses and spatial location of D(2cm(3)) volumes of OARs during MR-image based cervix brachytherapy.
Twenty-seven patients treated with EMBRACE protocol were analyzed. Every patient had two applications, one week apart. For each application patient had undergone MR-imaging (MR-1 and MR-2), volume delineation, reconstruction, treatment planning (plan-1 and plan-2) and dose evaluation. Both the image series were then co-registered with applicator as the reference coordinate system (Eclipse planning system v8.6.14). Inter-application dose, volume and spatial location of D(2cm(3)) variation were evaluated.
The largest inter-application systematic and random dose variations were observed for sigmoid as compared to rectum and bladder. The mean (±SD) of the relative D(2cm(3)) variations were 0.6(±15.1)%, 0.9(±13.1)% and 11.9(±37.5)% for rectum, bladder and sigmoid respectively. The overlap of D(2cm(3)) volumes was more than 50% in 16(59%), 8(30%) and 3(11%) patients for rectum, bladder and sigmoid, respectively.
The 2cm(3) volumes between the applications/fractions are quite stable in topography for bladder and rectum, and hence the current practice of cumulative addition of D(2cm(3)) dose is expected to be valid for bladder and rectum. For sigmoid, significant topographical changes were seen, which need further validation in a larger patient population and in multi-centric settings.
评估基于磁共振成像的宫颈癌近距离治疗中 OAR 的 D(2cm(3))体积的剂量和空间位置在不同应用之间的变化。
对采用 EMBRACE 方案治疗的 27 例患者进行分析。每位患者接受了两次治疗,间隔一周。对于每个应用,患者都进行了磁共振成像(MR-1 和 MR-2)、体积勾画、重建、治疗计划(计划-1 和计划-2)和剂量评估。然后,将两个图像系列与施源器一起进行配准(Eclipse 计划系统 v8.6.14)。评估了不同应用之间的剂量、体积和 D(2cm(3))位置的变化。
与直肠和膀胱相比,乙状结肠的剂量变化在系统性和随机性方面最大。直肠、膀胱和乙状结肠的相对 D(2cm(3))变化的平均值(±标准差)分别为 0.6(±15.1)%、0.9(±13.1)%和 11.9(±37.5)%。对于直肠、膀胱和乙状结肠,分别有 16(59%)、8(30%)和 3(11%)名患者的 D(2cm(3))体积重叠超过 50%。
对于膀胱和直肠,两次治疗/分次之间的 2cm(3)体积在位置上相当稳定,因此累积添加 D(2cm(3))剂量的当前实践预计对膀胱和直肠是有效的。对于乙状结肠,观察到显著的位置变化,需要在更大的患者群体和多中心环境中进一步验证。